nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—Hydrocortamate—Eplerenone—coronary artery disease	0.149	0.166	CrCrCtD
Loteprednol—Cortisone acetate—Eplerenone—coronary artery disease	0.144	0.161	CrCrCtD
Loteprednol—Fluoxymesterone—Eplerenone—coronary artery disease	0.129	0.143	CrCrCtD
Loteprednol—Testosterone Propionate—Eplerenone—coronary artery disease	0.125	0.14	CrCrCtD
Loteprednol—Fludrocortisone—Eplerenone—coronary artery disease	0.125	0.14	CrCrCtD
Loteprednol—Methyltestosterone—Eplerenone—coronary artery disease	0.122	0.136	CrCrCtD
Loteprednol—Hydrocortisone—Eplerenone—coronary artery disease	0.102	0.114	CrCrCtD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—NRIP1—coronary artery disease	0.00272	0.0285	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—BHLHE40—coronary artery disease	0.00249	0.026	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—coronary artery disease	0.00243	0.0254	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—RXRG—coronary artery disease	0.00223	0.0233	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—BHLHE40—coronary artery disease	0.00181	0.0189	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—RXRG—coronary artery disease	0.00176	0.0184	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—RXRG—coronary artery disease	0.00171	0.0178	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SFRP4—coronary artery disease	0.00158	0.0166	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—coronary artery disease	0.00151	0.0157	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR3C2—coronary artery disease	0.0015	0.0156	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1B—coronary artery disease	0.00147	0.0154	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—coronary artery disease	0.00145	0.0151	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—coronary artery disease	0.00139	0.0146	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00137	0.0143	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—coronary artery disease	0.00135	0.0141	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—HADH—coronary artery disease	0.00131	0.0137	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—NR4A1—coronary artery disease	0.0013	0.0136	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—coronary artery disease	0.00129	0.0135	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—DAB2—coronary artery disease	0.00116	0.0121	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—coronary artery disease	0.0011	0.0115	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—ARNTL—coronary artery disease	0.0011	0.0115	CbGpPWpGaD
Loteprednol—Fludrocortisone—NR3C2—coronary artery disease	0.00107	0.165	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—coronary artery disease	0.00106	0.0111	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.00104	0.0108	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—coronary artery disease	0.00103	0.0108	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR4A1—coronary artery disease	0.00103	0.0108	CbGpPWpGaD
Loteprednol—Betamethasone—PLA2G1B—coronary artery disease	0.000919	0.142	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—ID3—coronary artery disease	0.000868	0.00907	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—coronary artery disease	0.000861	0.00901	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—GATA4—coronary artery disease	0.000856	0.00895	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—ESR2—coronary artery disease	0.000853	0.00892	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—LEP—coronary artery disease	0.000839	0.00877	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—RXRG—coronary artery disease	0.000832	0.0087	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—RETN—coronary artery disease	0.000832	0.0087	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—DUSP1—coronary artery disease	0.000827	0.00865	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—coronary artery disease	0.00081	0.00847	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.000786	0.00822	CbGpPWpGaD
Loteprednol—Hydrocortisone—CYP11B2—coronary artery disease	0.000756	0.117	CrCbGaD
Loteprednol—NR3C1—Circadian Clock—F7—coronary artery disease	0.000752	0.00786	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARG—coronary artery disease	0.000731	0.00764	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—NPPA—coronary artery disease	0.000729	0.00762	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—MAP2K3—coronary artery disease	0.000728	0.00761	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PLIN1—coronary artery disease	0.000727	0.0076	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—EGR2—coronary artery disease	0.000727	0.0076	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—coronary artery disease	0.000725	0.00758	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—CREB1—coronary artery disease	0.000721	0.00753	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.000719	0.00752	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.000719	0.00752	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—NR4A1—coronary artery disease	0.000705	0.00737	CbGpPWpGaD
Loteprednol—Prednisolone—NR3C2—coronary artery disease	0.000702	0.108	CrCbGaD
Loteprednol—Betamethasone—NR3C2—coronary artery disease	0.000688	0.106	CrCbGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—ESR2—coronary artery disease	0.000674	0.00705	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—NRIP1—coronary artery disease	0.000658	0.00688	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—EPAS1—coronary artery disease	0.000658	0.00688	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—SELE—coronary artery disease	0.000642	0.00671	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—coronary artery disease	0.00064	0.0067	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.000628	0.00657	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—MIF—coronary artery disease	0.000607	0.00635	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.000596	0.00623	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CEBPD—coronary artery disease	0.000586	0.00613	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—DVL1—coronary artery disease	0.000577	0.00603	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TIMP1—coronary artery disease	0.000552	0.00578	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—MEF2A—coronary artery disease	0.000536	0.0056	CbGpPWpGaD
Loteprednol—Dexamethasone—PLA2G1B—coronary artery disease	0.000534	0.0824	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IRF1—coronary artery disease	0.000534	0.00559	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PPARGC1A—coronary artery disease	0.000528	0.00552	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—SIRT1—coronary artery disease	0.000526	0.0055	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—JUNB—coronary artery disease	0.000523	0.00547	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—ESR1—coronary artery disease	0.000517	0.00541	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—ESR1—coronary artery disease	0.000517	0.00541	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—GATA4—coronary artery disease	0.00051	0.00533	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000507	0.0053	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—MEF2C—coronary artery disease	0.000476	0.00498	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—coronary artery disease	0.000476	0.00498	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARG—coronary artery disease	0.000472	0.00493	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—GJA1—coronary artery disease	0.000466	0.00487	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—coronary artery disease	0.000458	0.00479	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—coronary artery disease	0.000454	0.00475	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000441	0.00461	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—coronary artery disease	0.000434	0.00454	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000417	0.00436	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—coronary artery disease	0.000414	0.00433	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—HIF1A—coronary artery disease	0.000413	0.00432	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—ESR1—coronary artery disease	0.000409	0.00427	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—EDN1—coronary artery disease	0.000409	0.00427	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000405	0.00423	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—MAPK14—coronary artery disease	0.000404	0.00422	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL10—coronary artery disease	0.000404	0.00422	CbGpPWpGaD
Loteprednol—Dexamethasone—NR3C2—coronary artery disease	0.0004	0.0617	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CSF2—coronary artery disease	0.000399	0.00418	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—TNF—coronary artery disease	0.000388	0.00406	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—coronary artery disease	0.000378	0.00396	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—coronary artery disease	0.000377	0.00395	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARG—coronary artery disease	0.000373	0.0039	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000372	0.00389	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—GSK3B—coronary artery disease	0.000359	0.00376	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—coronary artery disease	0.000359	0.00376	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CSF2—coronary artery disease	0.000352	0.00368	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—coronary artery disease	0.00035	0.00366	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—BAX—coronary artery disease	0.000347	0.00363	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CREB1—coronary artery disease	0.000346	0.00362	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP1—coronary artery disease	0.000343	0.00359	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—HIF1A—coronary artery disease	0.00034	0.00356	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—AGT—coronary artery disease	0.000339	0.00355	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—PLAU—coronary artery disease	0.000337	0.00352	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—ADIPOQ—coronary artery disease	0.000326	0.00341	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—ESR1—coronary artery disease	0.000317	0.00332	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—SERPINE1—coronary artery disease	0.000316	0.00331	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IL6—coronary artery disease	0.000313	0.00327	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—TBX5—coronary artery disease	0.000304	0.00318	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—RXRG—coronary artery disease	0.000304	0.00318	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MMP1—coronary artery disease	0.000303	0.00316	CbGpPWpGaD
Loteprednol—Fluoxymesterone—ESR1—coronary artery disease	0.000302	0.0467	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000297	0.00311	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CREB1—coronary artery disease	0.000285	0.00298	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—coronary artery disease	0.000285	0.00298	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—coronary artery disease	0.000282	0.00295	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCL2—coronary artery disease	0.000279	0.00292	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000275	0.00288	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—coronary artery disease	0.000275	0.00288	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SOCS1—coronary artery disease	0.000274	0.00287	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SOCS3—coronary artery disease	0.000271	0.00283	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NKX2-5—coronary artery disease	0.000265	0.00278	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARGC1A—coronary artery disease	0.000265	0.00277	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—STAT5A—coronary artery disease	0.000262	0.00274	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR3C2—coronary artery disease	0.000258	0.0027	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—coronary artery disease	0.000254	0.00266	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—coronary artery disease	0.000254	0.00265	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—POMC—coronary artery disease	0.000251	0.00263	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CREB1—coronary artery disease	0.000251	0.00263	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000245	0.00257	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LPL—coronary artery disease	0.000242	0.00253	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—MEF2C—coronary artery disease	0.000239	0.0025	CbGpPWpGaD
Loteprednol—Dexamethasone—NOS2—coronary artery disease	0.000239	0.0368	CrCbGaD
Loteprednol—NR3C1—Gene Expression—AIMP1—coronary artery disease	0.000237	0.00248	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—coronary artery disease	0.000232	0.00243	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000229	0.0024	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CXCL8—coronary artery disease	0.000221	0.00231	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000214	0.00224	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000213	0.00222	CbGpPWpGaD
Loteprednol—Prednisone—CYP2C19—coronary artery disease	0.000209	0.0323	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—HIF1A—coronary artery disease	0.000207	0.00217	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000207	0.00216	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—AGT—coronary artery disease	0.000207	0.00216	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCND1—coronary artery disease	0.000206	0.00215	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LEP—coronary artery disease	0.000202	0.00212	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP9—coronary artery disease	0.0002	0.00209	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—coronary artery disease	0.000195	0.00203	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—TET1—coronary artery disease	0.000193	0.00202	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IL6ST—coronary artery disease	0.00019	0.00199	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000188	0.00197	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—GATA4—coronary artery disease	0.000186	0.00195	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000179	0.00187	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR4A1—coronary artery disease	0.000178	0.00186	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARG—coronary artery disease	0.000176	0.00184	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CREB1—coronary artery disease	0.000174	0.00182	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—TGFB1—coronary artery disease	0.000168	0.00176	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IGF1—coronary artery disease	0.000167	0.00175	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—coronary artery disease	0.000166	0.00173	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TGFB1—coronary artery disease	0.000165	0.00172	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NPPA—coronary artery disease	0.000162	0.0017	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SERPINE1—coronary artery disease	0.000159	0.00166	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.00015	0.00157	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000147	0.00153	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—RXRG—coronary artery disease	0.000146	0.00153	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—TBX5—coronary artery disease	0.000146	0.00153	CbGpPWpGaD
Loteprednol—Triamcinolone—PTGS2—coronary artery disease	0.000144	0.0222	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—coronary artery disease	0.000142	0.00149	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NKX2-5—coronary artery disease	0.000128	0.00134	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—CTGF—coronary artery disease	0.000127	0.00133	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SMG6—coronary artery disease	0.000124	0.0013	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NR3C2—coronary artery disease	0.000124	0.0013	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL6—coronary artery disease	0.000124	0.0013	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—YBX1—coronary artery disease	0.000121	0.00127	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ZFP36—coronary artery disease	0.000121	0.00127	CbGpPWpGaD
Loteprednol—Betamethasone—PTGS2—coronary artery disease	0.000118	0.0182	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ESR2—coronary artery disease	0.000116	0.00122	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—JUNB—coronary artery disease	0.000116	0.00122	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000116	0.00122	CbGpPWpGaD
Loteprednol—Prednisone—ALB—coronary artery disease	0.000116	0.0179	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000112	0.00117	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000111	0.00116	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP2C19—coronary artery disease	0.00011	0.017	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL6—coronary artery disease	0.000109	0.00114	CbGpPWpGaD
Loteprednol—Methyltestosterone—ALB—coronary artery disease	0.000109	0.0168	CrCbGaD
Loteprednol—NR3C1—Gene Expression—RPL17—coronary artery disease	0.000109	0.00114	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—coronary artery disease	0.000102	0.00106	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—AKT1—coronary artery disease	0.000101	0.00105	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TGFB1—coronary artery disease	0.0001	0.00105	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	9.45e-05	0.000988	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TNF—coronary artery disease	9.37e-05	0.000979	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—GATA4—coronary artery disease	8.96e-05	0.000937	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NR4A1—coronary artery disease	8.57e-05	0.000896	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TNF—coronary artery disease	8.1e-05	0.000847	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NPPA—coronary artery disease	7.81e-05	0.000816	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—IL6—coronary artery disease	7.56e-05	0.00079	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ESR1—coronary artery disease	7.06e-05	0.000738	CbGpPWpGaD
Loteprednol—Dexamethasone—PTGS2—coronary artery disease	6.85e-05	0.0106	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6—coronary artery disease	6.53e-05	0.000683	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARG—coronary artery disease	6.44e-05	0.000673	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PSMA6—coronary artery disease	6.27e-05	0.000656	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PSMB5—coronary artery disease	6.27e-05	0.000656	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—CTGF—coronary artery disease	6.13e-05	0.000641	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—SERPINE1—coronary artery disease	5.8e-05	0.000607	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ESR2—coronary artery disease	5.6e-05	0.000586	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—HSPA1A—coronary artery disease	5.6e-05	0.000586	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—JUNB—coronary artery disease	5.6e-05	0.000586	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SIRT1—coronary artery disease	4.51e-05	0.000472	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPP2CA—coronary artery disease	3.98e-05	0.000417	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PRKCD—coronary artery disease	3.91e-05	0.000409	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—MAPK14—coronary artery disease	3.46e-05	0.000362	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ESR1—coronary artery disease	3.4e-05	0.000355	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARG—coronary artery disease	3.1e-05	0.000324	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SERPINE1—coronary artery disease	2.79e-05	0.000292	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AKT1—coronary artery disease	1.23e-05	0.000128	CbGpPWpGaD
